Telmifree 40MG Tab

Tablet

Treatment of hypertension (high blood pressure); reduction of cardiovascular risk (heart attack, stroke) in high-risk patients when appropriate.

Telmisartan is an angiotensin II receptor blocker (ARB). It blocks AT1 receptors, preventing angiotensin II–mediated vasoconstriction and aldosterone release, thereby lowering blood pressure and reducing cardiovascular strain.

Take by mouth as prescribed, usually once daily, with or without food. Take at the same time each day; do not stop abruptly without medical advice. Dose adjustments may be needed in kidney/liver problems or if used with diuretics.

dizziness, headache, fatigue, low blood pressure, increased potassium (hyperkalemia), nausea

Not recommended in pregnancy (especially 2nd/3rd trimester) due to risk of fetal harm; avoid in breastfeeding unless advised. Use caution in kidney disease, renal artery stenosis, dehydration/low salt (may cause marked BP fall), and liver impairment. Monitor blood pressure, kidney function (creatinine) and serum potassium, especially after starting or dose changes. Do not use with aliskiren in diabetes; avoid dual blockade with ACE inhibitors/other ARBs unless specifically advised.

Potassium supplements/salt substitutes and potassium-sparing diuretics (spironolactone, eplerenone, amiloride) increase hyperkalemia risk; NSAIDs may reduce effect and worsen kidney function; lithium levels may increase; other antihypertensives/diuretics can increase hypotension; ACE inhibitors/aliskiren increase kidney and potassium risks.

Store below 25°C in a dry place, protected from moisture and direct light. Keep in original blister pack and out of reach of children.

Telma 40 Tablet, Telsar 40 Tablet, Telmikind 40 Tablet, Telpres 40 Tablet, Micardis 40 Tablet